Karen E. Knudsen

Active 1997–2024

111
Papers
20,367
Citations
80
h-index
111
i10-index

Citations

Citations per year for Karen E. Knudsen1997: 13 citations1998: 19 citations1999: 28 citations2000: 33 citations2001: 42 citations2002: 84 citations2003: 46 citations2004: 47 citations2005: 54 citations2006: 66 citations2007: 72 citations2008: 85 citations2009: 92 citations2010: 116 citations2011: 125 citations2012: 128 citations2013: 151 citations2014: 161 citations2015: 212 citations2016: 243 citations2017: 276 citations2018: 283 citations2019: 836 citations2020: 909 citations2021: 919 citations2022: 785 citations2023: 560 citations2024: 916 citations2025: 413 citations2026: 5 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,119 citing papers, 31.3% of this breakdownChina: 1,192 citing papers, 11.9% of this breakdownUnited Kingdom: 625 citing papers, 6.3% of this breakdownCanada: 479 citing papers, 4.8% of this breakdownItaly: 447 citing papers, 4.5% of this breakdownGermany: 367 citing papers, 3.7% of this breakdownAustralia: 334 citing papers, 3.3% of this breakdownFrance: 309 citing papers, 3.1% of this breakdownSpain: 264 citing papers, 2.6% of this breakdownJapan: 236 citing papers, 2.4% of this breakdownNetherlands: 188 citing papers, 1.9% of this breakdownSwitzerland: 186 citing papers, 1.9% of this breakdown
0%31.3%Other 22.3%

Fields

  • Medicine50.4%
  • Biochemistry, Genetics and Molecular Biology39.9%
  • Environmental Science3.9%
  • Neuroscience2.1%
  • Immunology and Microbiology1.2%
  • Agricultural and Biological Sciences0.5%
  • Other2%

Topics

  • Prostate Cancer Treatment and Research9.6%
  • PARP inhibition in cancer therapy4.2%
  • Prostate Cancer Diagnosis and Treatment3.8%
  • Cancer-related Molecular Pathways3.4%
  • DNA Repair Mechanisms3.2%
  • Cancer Genomics and Diagnostics2.8%
  • Other73%

Coauthors

All papers

Open in search
  1. Prostate cancer

    Authors: , , , , , , , , - Nature Reviews Disease Primers 2021 cited by 1,109

  2. DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bernardette Ebbs, Gemma Fowler, Desamparados Roda, Wei Yuan, Yi‐Mi Wu, Xuhong Cao, Rachel Brough, Helen N. Pemberton, Roger A’Hern, Amanda Swain, Lakshmi P. Kunju, Rosalind A. Eeles, Gerhardt Attard, Christopher J. Lord, Alan Ashworth, Mark A. Rubin, Karen E. Knudsen, Felix Y. Feng, Arul M. Chinnaiyan, Emma Hall, Johann S. de Bono - New England Journal of Medicine 2015 cited by 2,187

  3. Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jonathan Chou, Haolong Li, Rajdeep Das, Hui Li, Ruhollah Moussavi-Baygi, Hani Goodarzi, Luke A. Gilbert, Primo N. Lara, Christopher P. Evans, Theodore C. Goldstein, Joshua M. Stuart, Scott A. Tomlins, Daniel E. Spratt, R. Keira Cheetham, Donavan T. Cheng, Kyle Kai‐How Farh, Julian Gehring, Jörg Hakenberg, Arnold Liao, Philip G. Febbo, John Shon, Brad Sickler, Serafim Batzoglou, Karen E. Knudsen, Housheng Hansen He, Jiaoti Huang, Alexander W. Wyatt, Scott M. Dehm, Alan Ashworth, Arul M. Chinnaiyan, Christopher A. Maher, Eric J. Small, Felix Y. Feng - Cell 2018 cited by 759

  4. Targeting the p300/CBP Axis in Lethal Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nina Tunariu, Suzanne Carreira, Antje Neeb, Jian Ning, Amanda Swain, David Taddei, SU2C/PCF International Prostate Cancer Dream Team, Matthew J. Schiewer, Karen E. Knudsen, Neil Pegg, Johann S. de Bono - Cancer Discovery 2021 cited by 284

  5. The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William L. Dahut, Peter S. Nelson - Clinical Cancer Research 2019 cited by 394

  6. The DNA methylation landscape of advanced prostate cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert E. Reiter, Matthew B. Rettig, Owen N. Witte, M. Yvonne Kim, Lawrence Fong, Daniel E. Spratt, Todd M. Morgan, Rohit Bose, Franklin W. Huang, Hui Li, Lisa N. Chesner, Tanushree Shenoy, Hani Goodarzi, Irfan A. Asangani, Shahneen Sandhu, Joshua M. Lang, Nupam P. Mahajan, Primo N. Lara, Christopher P. Evans, Phillip G. Febbo, Serafim Batzoglou, Karen E. Knudsen, Housheng Hansen He, Jiaoti Huang, Wilbert Zwart, J Costello, Jianhua Luo, Scott A. Tomlins, Alexander W. Wyatt, Scott M. Dehm, Alan Ashworth, Luke A. Gilbert, Paul C. Boutros, Kyle Kai‐How Farh, Arul M. Chinnaiyan, Christopher A. Maher, Eric J. Small, David A. Quigley, Felix Y. Feng - Nature Genetics 2020 cited by 353

  7. Cancer and the Circadian Clock

    Authors: , - Cancer Research 2019 cited by 273

  8. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jacqueline Powers, Raoul S. Concepcion, Daniel W. Lin, Richard C. Wender, James Ryan Mark, Anthony J. Costello, Arthur L. Burnett, Oliver Sartor, William B. Isaacs, Jianfeng Xu, Jeffrey N. Weitzel, Gerald L. Andriole, Himisha Beltran, Alberto Briganti, Lindsey Byrne, Anne Calvaresi, Thenappan Chandrasekar, David Y.T. Chen, Robert B. Den, Albert Dobi, E. David Crawford, James A. Eastham, Scott E. Eggener, Matthew L. Freedman, Marc B. Garnick, Patrick T. Gomella, Nathan Handley, Mark Hurwitz, Joseph K. Izes, R. Jeffrey Karnes, Costas D. Lallas, Lucia R. Languino, Stacy Loeb, Ana María López, Kevin R. Loughlin, Grace Lu‐Yao, S. Bruce Malkowicz, Mark Mann, Patrick Mille, Martin Miner, Todd M. Morgan, José Moreno, Lorelei A. Mucci, Ronald E. Myers, Sarah M. Nielsen, Brock O’Neil, Wayne H. Pinover, Peter A. Pinto, Wendy Poage, Ganesh V. Raj, Timothy R. Rebbeck, Charles J. Ryan, Howard M. Sandler, Matthew J. Schiewer, Emily Scott, Brittany M. Szymaniak, William Tester, Edouard J. Trabulsi, Neha Vapiwala, Evan Y. Yu, Charnita Zeigler‐Johnson, Leonard G. Gomella - Journal of Clinical Oncology 2020 cited by 279

  9. Dual Roles of PARP-1 Promote Cancer Growth and Progression

    Authors: , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2012 cited by 446

  10. Analysis of Circulating Cell-Free DNA Identifies Multiclonal Heterogeneity of BRCA2 Reversion Mutations Associated with Resistance to PARP Inhibitors

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2017 cited by 268

  11. Disparities and Trends in Genitourinary Cancer Incidence and Mortality in the USA

    Authors: , , , , , , , - European Urology 2022 cited by 104

  12. Beyond DNA Repair: DNA-PK Function in Cancer

    Authors: , - Cancer Discovery 2014 cited by 255

  13. RB/E2F1 as a Master Regulator of Cancer Cell Metabolism in Advanced Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2021 cited by 98

  14. DNA-PKcs: A Targetable Protumorigenic Protein Kinase

    Authors: , - Cancer Research 2021 cited by 62

  15. A Hormone–DNA Repair Circuit Governs the Response to Genotoxic Insult

    Authors: , , , , , , , , , , - Cancer Discovery 2013 cited by 368

  16. Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cell 2018 cited by 159

  17. The Long Non-Coding RNA PCAT-1 Promotes Prostate Cancer Cell Proliferation through cMyc

    Authors: , , , , , , , , , , , , - Neoplasia 2014 cited by 254

  18. Transcriptional Roles of PARP1 in Cancer

    Authors: , - Molecular Cancer Research 2014 cited by 189

  19. The circadian cryptochrome, CRY1, is a pro-tumorigenic factor that rhythmically modulates DNA repair

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Communications 2021 cited by 131

  20. A patient‐derived explant (PDE) model of hormone‐dependent cancer

    Authors: , , , , , , , , , , , , , , , , , , , - Molecular Oncology 2018 cited by 131

  21. Control of CCND1 ubiquitylation by the catalytic SAGA subunit USP22 is essential for cell cycle progression through G1 in cancer cells

    Authors: , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2018 cited by 125

  22. Optimizing the Use of Telemedicine in Oncology Care: Postpandemic Opportunities

    Authors: , , - Clinical Cancer Research 2020 cited by 91

  23. The retinoblastoma tumor suppressor controls androgen signaling and human prostate cancer progression

    Authors: , , , , , , , , , , , , , - Journal of Clinical Investigation 2010 cited by 332

  24. A Randomized Phase II Study of Androgen Deprivation Therapy with or without Palbociclib in RB-positive Metastatic Hormone-Sensitive Prostate Cancer

    Authors: , , , , , , , , , , , , , , , - Clinical Cancer Research 2021 cited by 59